Search alternatives:
larger decrease » marked decrease (Expand Search)
less decrease » we decrease (Expand Search), levels decreased (Expand Search), largest decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
less decrease » we decrease (Expand Search), levels decreased (Expand Search), largest decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
-
4161
Immune Cell Correlation Analysis.
Published 2025“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
-
4162
GO Enrichment Analysis.
Published 2025“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
-
4163
Differential Analysis.
Published 2025“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
-
4164
GO Diagram.
Published 2025“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
-
4165
Hub Genes.
Published 2025“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
-
4166
PPI.
Published 2025“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
-
4167
Download Data.
Published 2025“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
-
4168
Heatmap.
Published 2025“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
-
4169
Figure 2.
Published 2025“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
-
4170
KEGG Enrichment Analysis.
Published 2025“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
-
4171
Figure 1.
Published 2025“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
-
4172
Gene Name to ID Conversion.
Published 2025“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
-
4173
Bar Chart.
Published 2025“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
-
4174
Filter Samples with p < 0.05.
Published 2025“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
-
4175
KEGG Diagram.
Published 2025“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
-
4176
Grouping and Sorting.
Published 2025“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
-
4177
Violin Plot.
Published 2025“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
-
4178
XCell Algorithm for Immune Cell Matrix.
Published 2025“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
-
4179
Droperidol is associated with reduced length of stay in the treatment of cannabinoid hyperemesis syndrome
Published 2025“…After adjustments, droperidol use was associated with a reduced length of stay (mean ratio 0.76; 95% CI: 0.62 0.94; <i>P</i> = 0.01), decreased total medication administration (OR 0.34; 95% CI: 0.20–0.58; <i>P <</i>0.001) and decreased usage of opioids (OR 0.16; 95% CI: 0.07–0.39; <i>P <</i>0.001). …”
-
4180
CCDC66 localizes to the axoneme and regulates primary cilium stability but not cilia formation in IMCD3 cells.
Published 2025“…<i>n</i> > 600 cells for control and >400 cells for CCDC66 depletion. The mean cilia length in CCDC66-depleted cells decreased to 0.67-fold compared to the mean control length. …”